Yaoming Bio: It is expected that the income in the first half of 2022 increases by 61%to 63%year -on -year

On July 19, 2022, Yaoming Biological (02269.HK) announced positive profit trailers.

The Group expects to compare the same period with the same period last year. As of June 30, 2022, the company's revenue recorded by 6 months will increase by 61%to 63%; the company's profit and the profit attributable to the company's equity shareholders will increase by 36 in the same period last year, respectively. %To 38%and 35%to 37%; and after adjustment of shares, the company's non -international financial report standards will increase by 58%to 60%after adjustment of the net financial reporting standards.

The company said that these growths are mainly due to: (i) successfully executed the group's "follow -up and winner" strategy, thereby continuing to increase the number of customers The business continues the development of the first year of commercial production in the first year of commercial production, and promotes the significant growth of income; (III) accelerate the efficient promotion of existing and newly introduced projects; Preparation services, improve the group's income; and (v) make full use of existing capacity and resources and implementation of operating efficiency to improve projects, plus the successful implementation of business continuity plans in Shanghai, and so on.

In addition, the company pointed out that the growth of income during the reporting period was higher than the increase in profit growth because the first half of 2021 was a special period of recording a very high profit margin. The group paid huge efforts to promote the implementation of the implementation of the growth of employees as much as possible as possible. A large number of new comprehensive projects. In the first half of 2022, the group's required talents, continuous construction capacity and global networks, and further increased R & D expenditure to ensure the Group's long -term sustainable growth.

As of, Yaoming Bio rose 2.16%to HK $ 77.95, with the latest market value of HK $ 332.1 billion.

- END -